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Background. Besides its involvement in peripheral myelin maintenance, the physiologic 
function of the ubiquitously expressed cellular prion protein PrP
C
 remains enigmatic. 
Phenotypic studies on previously available Prnp
-/-
 mouse lines, produced in 129-derived 
embryonic stem cells and backcrossed to non-129 strains, were systematically confounded by 
Prnp-linked loci polymorphic between 129 and the backcrossing strain and have led to 
erroneous conclusions [1]. We have recently applied genome-editing to generate a novel co-
isogenic Prnp
-/- 
mouse line (termed ZH3 line) in the well characterized C57BL/6J background 
[2]. Genetic and phenotypic characterization of this line excluded the presence of artefactual 
phenotypes reported in non-co-isogenic Prnp
-/-
 mouse lines and confirmed the crucial 
involvement of PrP
C
 in peripheral myelin maintenance through the interaction with Gpr126
 
[2, 3]. Here, we aimed at extending the characterization of the Prnp
ZH3/ZH3 
mouse line.  
 
Materials and methods. Data on single nucleotide polymorphism (SNPs) informative among 
different C57BL/6 substrains were extrapolated from a whole-genome SNP analysis 
performed as previously described [2]. Genotyping protocols to investigate the presence of 
mutations/deletions in Crb1, Snca/Mmrn1 and Nnt were as previously described [4, 5, 6]. 
Prion inoculations and relative analyses were all performed as previously described [7]. 
 
Results. Since its establishment, the C57BL/6 inbred strain has led to the origin of several 
substrains, which differ genetically and phenotypically with respect to the reference 
C57BL/6J [8]. To verify the genetic makeup of the Prnp
ZH3/ZH3
 mouse line, we analyzed 12 
SNPs known to be informative among different C57BL/6 substrains. The Prnp
ZH3/ZH3
 line 
showed an allelotype identical to the C57BL/6J reference strain (Figure 1A). We next 
investigated the Prnp
ZH3/ZH3
 line for the presence of specific deletions or mutations reported in 
different C57BL/6 substrains using established genotyping assays. The Prnp
ZH3/ZH3
 line 
showed the presence of the partial deletion of Nnt, described in the C57BL/6J reference strain 
[6], but not of the Rd8 mutation of the Crb1 gene, described in the C57BL/6N strain [4], nor 
the deletion of Snca/Mmrn1, reported in the C57BL/6JOlaHsd strain [5] (Figure 1A). 
Collectively, these data confirmed that the Prnp
ZH3/ZH3
 line is indistinguishable with respect to 
the C57BL/6J reference strain in all investigated genomic loci. 
Expression of membrane-bound PrP
C
 is necessary to sustain the replication and neurotoxicity 
of prions and mice devoid of PrP
C
 resist prion infection. To verify prion resistance of the 
novel knockout line, we intracerebrally inoculated Prnp
ZH3/ZH3
 and C57BL/6J wild-type mice 
with the 22L prion strain or with non-infectious brain homogenate (NBH) as control. Only 
22L-inoculated C57BL/6J wild-type mice developed typical signs of scrapie and achieved the 
terminal stage of the disease with a median incubation of 141 days post-injection. Conversely, 
NBH-injected C57BL/6J wild-type mice and both 22L- and NBH-injected Prnp
ZH3/ZH3
 mice 
showed no clinical signs of scrapie and survived more than 200 days (Figure 1B). Histological 
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analysis confirmed the presence of spongiosis and accumulation of the partially-protease 
resistant prion protein, typical hallmarks of prion disease, only in 22L-inoculated C57BL/6J 
wild-type mice and not in any other experimental group. Altogether, these data confirmed the 
prion resistance of the Prnp
ZH3/ZH3
 mouse line. 
 
 




reference C57BL/6 substrains. 
X denotes presence of a specific 
mutation/deletion. B. Survival 
after injection with prions (22L) 
or control (NBH). n denotes the 
number of mice in each group. 
C. Histologic analysis of 
cerebelli of representative mice 
from B. SAF84 shows partially 
protease resistant prion protein. 
Scale bar: 100 µm.   
 
Discussion and conclusions. This study confirms the co-isogenicity of the Prnp
ZH3/ZH3
 line 
with the C57BL/6J reference strain and its resistance to prion infection. Together with the 
extensive genomic, transcriptomic and phenotypic characterization reported [2, 3], this study 
corroborates the notion the Prnp
ZH3/ZH3
 line is a rigorous genetic resource for investigating the 
role of PrP
C
 in physiology and disease. 
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